Leerink upgraded Quest Diagnostics (DGX) to Outperform from Market Perform with a price target of $174, up from $169. The firm notes its view ...

OhioHealth Corp. has outsourced some lab work to Quest Diagnostics Inc., part of a growing healthcare trend. Quest (NYSE:DGX) ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

With a market cap of $19.2 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company specializing in ...

Quest has been a leading provider of diagnostic information services with over 70 billion data points based on de-identified ...

Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.

Only 20 full-company mergers or acquisitions occurred throughout the year, although asset acquisition deals were more common.

announced today an agreement with Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, to support commercialization of Mainz Biomed’s NextGen screening test for ...

Mainz Biomed’s ColoAlert test has shown promising sensitivity and specificity in identifying colorectal cancer, including advanced adenomas, in preliminary data. Quest will provide clinical trial ...

LOS ANGELES, Dec. 18, 2024 /PRNewswire/ -- Pharus Diagnostics ... (a CLIA-accredited laboratory) in Irvine, California, aligns with PharusDx’s commitment to advancing early cancer detection. By ...

where Baystate continues to provide professional support anatomic pathology and select specialty testing at its existing laboratory. 7. Quest Diagnostics on Jan. 8 acquired select assets of Dallas ...

Independent lab companies often can provide a higher volume of tests at a lower cost compared with hospitals performing tests at their own facilities.